Kristin Ficks Ainsworth
Direktor/Vorstandsmitglied bei Women Who Conquer Cancer
Profil
Kristin Ficks Ainsworth is currently the Director at Women Who Conquer Cancer and a Member at Healthcare Businesswomens Association.
Previously, she held positions as Vice President-Global Marketing at Celgene Corp.
and Vice President-Marketing at Tesaro, Inc. From 2021 to 2023, she served as the Senior Vice President-Communications at Seres Therapeutics, Inc. Ms. Ainsworth completed her undergraduate degree at the University of Iowa and holds an MBA from The Curtis L.
Carlson School of Management.
Aktive Positionen von Kristin Ficks Ainsworth
| Unternehmen | Position | Beginn |
|---|---|---|
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Corporate Officer/Principal | - |
| Women Who Conquer Cancer | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kristin Ficks Ainsworth
| Unternehmen | Position | Ende |
|---|---|---|
| SERES THERAPEUTICS, INC. | Public Communications Contact | 28.02.2023 |
| CELGENE | Vertrieb & Marketing | - |
| TESARO INC | Vertrieb & Marketing | - |
Ausbildung von Kristin Ficks Ainsworth
| University of Iowa | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Healthcare Businesswomens Association
Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Commercial Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
| Women Who Conquer Cancer |
